These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9853232)

  • 41. Immunotherapy for renal cell carcinoma.
    Rosenblatt J; McDermott DF
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):793-812. PubMed ID: 21763968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chances for the success of cytokine therapy in metastatic renal cell cancer].
    Kriegmair M
    Fortschr Med; 1992 Aug; 110(24):435-6. PubMed ID: 1398389
    [No Abstract]   [Full Text] [Related]  

  • 43. Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes.
    Sherif AM; Eriksson E; Thörn M; Vasko J; Riklund K; Ohberg L; Ljungberg BJ
    BJU Int; 2012 Apr; 109(8):1134-9. PubMed ID: 21883833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma.
    Belldegrun A; Pierce W; Kaboo R; Tso CL; Shau H; Turcillo P; Moldawer N; Golub S; deKernion J; Figlin R
    J Urol; 1993 Nov; 150(5 Pt 1):1384-90. PubMed ID: 8411405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A Case of ACD-Associated RCC with Lymph Node Metastasis and Contralateral Renal Carcinoma after Nephrectomy].
    Makino Y; Tsuchihashi K; Shimizu Y; Kanamaru S; Hashimoto K; Ito N
    Hinyokika Kiyo; 2016 Jul; 62(7):349-53. PubMed ID: 27569352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma.
    van Herpen CM; De Mulder PH
    Crit Rev Oncol Hematol; 2002 Mar; 41(3):327-34. PubMed ID: 11880208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A case report of markedly effective recombinant interferon therapy in residual tumor of renal cell carcinoma].
    Shimura H; Hara Y; Ida T
    Hinyokika Kiyo; 1993 Mar; 39(3):261-3. PubMed ID: 8506799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bladder metastasis of renal cell carcinoma; a case study.
    Kagota M; Irie K; Hosaka K; Takezaki T
    Hinyokika Kiyo; 2007 Aug; 53(8):571-4. PubMed ID: 17874550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie.
    Negrier S; Escudier B; Lasset C; Douillard JY; Savary J; Chevreau C; Ravaud A; Mercatello A; Peny J; Mousseau M; Philip T; Tursz T
    N Engl J Med; 1998 Apr; 338(18):1272-8. PubMed ID: 9562581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative embolization in the treatment of spinal metastasis from renal cell carcinoma--a case report.
    Chung CY; Huang TJ; Hsu RW
    Changgeng Yi Xue Za Zhi; 1994 Sep; 17(3):264-7. PubMed ID: 7954006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
    Stadler WM; Kuzel T; Dumas M; Vogelzang NJ
    J Clin Oncol; 1998 May; 16(5):1820-5. PubMed ID: 9586896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Solitary breast mass as initial presentation of clinically silent metastatic renal cell carcinoma.
    McLauglin SA; Thiel DD; Smith SL; Wehle MJ; Menke DM
    Breast; 2006 Jun; 15(3):427-9. PubMed ID: 16289905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck.
    Paiva MB; Sercarz JA; Pantuck AJ; Polyakov M; Figlin RA; Canalis RF; Castro DJ
    Lasers Med Sci; 2007 Mar; 22(1):60-3. PubMed ID: 17219256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine therapy for metastatic renal cell carcinoma.
    Bukowski RM
    Semin Urol Oncol; 2001 May; 19(2):148-54. PubMed ID: 11354535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study.
    Spencer WF; Linehan WM; Walther MM; Haas GP; Lotze MT; Topalian SL; Yang JC; Merino MJ; Lange JR; Pockaj BA
    J Urol; 1992 Jan; 147(1):24-30. PubMed ID: 1729540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quiz case of the month. Diagnosis: clear-cell renal cell carcinoma (RCC) with metastasis to lung, mediastinal and abdominal lymph nodes and bones.
    Koç M; Polat P; Erem T; Büyükavci M; Ozbey I; Gündogdu C; Suma S
    Eur Radiol; 1999; 9(9):1935-6. PubMed ID: 10602983
    [No Abstract]   [Full Text] [Related]  

  • 57. Removing the primary tumor after the cancer has spread.
    Tannock IF
    N Engl J Med; 2001 Dec; 345(23):1699-700. PubMed ID: 11759650
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation.
    Brinkmann OA; Bruns F; Gosheger G; Micke O; Hertle L
    World J Urol; 2005 Jul; 23(3):185-90. PubMed ID: 15838689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Renal cell carcinoma metastatic to the base of tongue: a case report].
    Kyan A; Kato SN
    Hinyokika Kiyo; 2004 Nov; 50(11):791-3. PubMed ID: 15628540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Advanced renal cell carcinoma showing a different response to two types of interferon-alpha].
    Horiguchi A; Uchida A
    Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):50-3. PubMed ID: 14978941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.